UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ | Preliminary Proxy Statement | |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
☐ | Definitive Proxy Statement | |
☒ | Definitive Additional Materials | |
☐ | Soliciting Material under §240.14a-12 |
Laboratory Corporation of America Holdings
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☒ | No fee required. | |||
☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
(1) | Title of each class of securities to which transaction applies:
| |||
(2) | Aggregate number of securities to which transaction applies:
| |||
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
| |||
(4) | Proposed maximum aggregate value of transaction:
| |||
(5) | Total fee paid:
| |||
☐ | Fee paid previously with preliminary materials. | |||
☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||
(1) | Amount Previously Paid:
| |||
(2) | Form, Schedule or Registration Statement No.:
| |||
(3) | Filing Party:
| |||
(4) | Date Filed:
|
*** Exercise Your Right to Vote ***
Important Notice Regarding the
Availability of Proxy Materials for the Stockholder Meeting to Be Held on May 13, 2020.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Meeting Information
Meeting Type: Annual Meeting
For holders as of: March 25, 2020
Date: May 13, 2020 Time: 9:00 A.M. EDT
Location: Meeting live via the Internet-please visit www.virtualshareholdermeeting.com/LH2020
The company will be
hosting the meeting live via the Internet this year. To attend the meeting via the Internet please visit www.virtualshareholdermeeting.com/LH2020 and be sure to have the information that is printed in the box marked by the arrow XXXX XXXX XXXX XXXX
(located on the following page).
LABORATORY CORPORATION OF AMERICA HOLDINGS 358 SOUTH MAIN STREET
BURLINGTON, NC 27215
You are receiving this communication because you hold shares in the company
named above.
This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that
are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).
We encourage you to
access and review all of the important information contained in the proxy materials before voting.
See proxy the materials reverse and side voting of this instructions
notice to obtain .
D05646-P36519
Before You Vote
How to Access the Proxy Materials
Proxy Materials Available to VIEW or RECEIVE:
NOTICE AND PROXY STATEMENT ANNUAL REPORT
How to View Online:
Have the information that is printed in the box marked by the arrow XXXX XXXX XXXX XXXX
(located on the
following page) and visit: www.proxyvote.com.
How to Request and Receive a PAPER
or E-MAIL Copy:
If you want to receive a paper or e-mail copy of these documents, you must
request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
1) BY INTERNET: www.proxyvote.com 2) BY TELEPHONE: 1-800-579-1639 3) BY E-MAIL*: sendmaterial@proxyvote.com
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the
box marked by the arrow XXXX XXXX XXXX XXXX (located on the following page) in the subject line. Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment
advisor. Please make the request as instructed above on or before April 29, 2020 to facilitate timely delivery.
How To Vote Please Choose One of the Following Voting
Methods
Vote By Internet: Before The Meeting:
Go to www.proxyvote.com. Have the information that
is printed in the box marked by the arrowXXXX XXXX XXXX XXXX (located on the following page) available and follow the instructions. During The Meeting:
Go to
www.virtualshareholdermeeting.com/LH2020. Have the information that is printed in the box marked by the arrowï§XXXX XXXX XXXX XXXX (located on the following page) available and follow the instructions. Vote By Mail: You can vote by mail by
requesting a paper copy of the materials, which will include a proxy card. Vote By Telephone: Go to www.proxyvote.com to view the materials and to obtain the telephone number to call. Have information that is printed in the box marked by the arrow
XXXX XXXX XXXX XXXX (located on the following page) available and follow the instructions.
D05647-P36519
The Board of Directors recommends you vote FOR each of the Nominees listed in the following proposal:
1. Election of the members of the Companys Board of Directors.
Nominees:
1a. Kerrii B. Anderson
1b. Jean-Luc Bélingard
1c. Jeffrey A. Davis
1d. D. Gary Gilliland, M.D., Ph.D.
1e. Garheng Kong, M.D., Ph.D.
1f. Peter M. Neupert
1g. Richelle P. Parham
1h. Adam H. Schechter
1i. R. Sanders Williams, M.D.
The Board of Directors recommends you vote FOR
the following proposals:
2. To approve, by non-binding vote, executive
compensation.
3. Ratification of the appointment of PricewaterhouseCoopers LLP as Laboratory Corporation of America Holdings independent registered public accounting
firm for 2020.
The Board of Directors recommends you vote
AGAINST the following proposal:
4. Shareholder proposal seeking the power for shareholders of 10% or more of our common stock to call a special shareholder meeting.
NOTE: Such other business as may properly come before the meeting or any adjournment thereof.
D05648-P36519
D05649-P36519